Kenneth B. Adler

Corporate Officer/Principal at North Carolina State University

Consumer Services

Health Technology

Profile

Kenneth B.
Adler is the founder of BioMarck Pharmaceuticals Ltd.
which was founded in 2002.
He held the title of Chief Scientist.
Currently, Dr. Adler is a Professor at North Carolina State University.
Dr. Adler received a doctorate degree from the University of Vermont.

Kenneth B. Adler active positions

Companies	Position	Start
North Carolina State University	Corporate Officer/Principal	-

All active positions of Kenneth B. Adler

Former positions of Kenneth B. Adler

Companies	Position	End
BioMarck Pharmaceuticals Ltd. BioMarck Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology BioMarck Pharmaceuticals Ltd. engages in the discovery and development of new drugs for the treatment of pulmonary diseases and disorders. It develops its lead compound, BIO-11006 Inhalation Solution, BioMarck has chosen chronic obstructive pulmonary disease (specifically chronic bronchitis) as its first target, but other diseases including asthma and cystic fibrosis are later disease targets. The company was founded by Indu Parikh, Allen F. Gant, Thomas H. Roberg and Kenneth Adl in 2002 and is headquartered in Durham, NC.	Founder	-

See the detail of Kenneth B. Adler's experience

Training of Kenneth B. Adler

University of Vermont

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kenneth B. Adler's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
BioMarck Pharmaceuticals Ltd. BioMarck Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology BioMarck Pharmaceuticals Ltd. engages in the discovery and development of new drugs for the treatment of pulmonary diseases and disorders. It develops its lead compound, BIO-11006 Inhalation Solution, BioMarck has chosen chronic obstructive pulmonary disease (specifically chronic bronchitis) as its first target, but other diseases including asthma and cystic fibrosis are later disease targets. The company was founded by Indu Parikh, Allen F. Gant, Thomas H. Roberg and Kenneth Adl in 2002 and is headquartered in Durham, NC.	Health Technology